[1]安亚文 刘汉清 综述 袁 波 王建春 李炜昕 王 诚 审校.生物钟基因在胶质瘤中的作用研究进展[J].中国临床神经外科杂志,2020,(01):51-53.[doi:10.13798/j.issn.1009-153X.2020.01.019]
点击复制

生物钟基因在胶质瘤中的作用研究进展()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年01期
页码:
51-53
栏目:
综述
出版日期:
2020-01-25

文章信息/Info

文章编号:
1009-153X(2020)01-0051-03
作者:
安亚文 刘汉清 综述 袁 波 王建春 李炜昕 王 诚 审校
518118 广东,深圳市萨米医疗中心神经外科(安亚文、刘汉清、袁 波、王建春、李炜昕、王 诚)
关键词:
脑胶质瘤生物钟基因CRY基因CLOCK基因
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2020.01.019
文献标志码:
A

参考文献/References:

[1] 安 扬,徐 璎. 哺乳动物昼夜节律机制研究进展[J]. 生 命科学,2015,27(11):1372-1379.
[2] Verlande A, Masri S. Circadian clocks and cancer: time- keeping governs cellular metabolism [J]. Trends Endocrinol Metab, 2019, 30(7): 445-458.
[3] Masri S, Sassone-Corsi P. The emerging link between can- cer, metabolism, and circadian rhythms [J]. Nat Med, 2018, 24(12): 1795-1803.
[4] Chen ST, Choo KB, Hou MF, et al. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers [J]. Carcinogenesis, 2005, 26(7): 1241-1246.
[5] Zhu Y, Stevens RG, Hoffman AE, et al. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study [J]. Cancer Res, 2009, 69(24): 9315- 9322.
[6] Papagiannakopoulos T, Bauer MR, Davidson SM, et al. Cir- cadian rhythm disruption promotes lung tumorigenesis [J]. Cell Metab, 2016, 24(2):324-331.
[7] Mazzoccoli G, Colangelo T, Panza A, et al. Deregulated ex- pression of cryptochrome genes in human colorectal cancer [J]. Mol Cancer, 2016, 15: 6.
[8] 国家卫生健康委员会医政医管局. 脑胶质瘤诊疗规范 (2018年版)[J]. 中华神经外科杂志,2019,35(3):217- 239.
[9] 代从新,王 裕,马文斌. 中央区胶质瘤的手术治疗进展 [J]. 中华医学杂志,2019,99(35):2797-2800.
[10] 赛 克,陈忠平. 胶质瘤的疗效评价[J]. 中国临床神经外 科杂志,2016,21(6):321-322.
[11] 李成婧,吴晓明. 神经胶质瘤对替莫唑胺耐药机制的研究 [J]. 当代医药论丛,2019,17(7):51-52.
[12] Dong Z, Zhang G, Qu M, et al. Targeting glioblastoma stem cells through disruption of the circadian clock [J]. Cancer Discov, 2019, 9(11): 1556-1573.
[13] Chiou YY, Yang Y, Rashid N, et al. Mammalian period represses and de-represses transcription by displacing CLOCK-BMAL1 from promoters in a Cryptochrome- dependent manner [J]. Proc Natl Acad Sci USA, 2016, 113 (41): E6072-E6079.
[14] Madden MH, Anic GM, Thompson RC, et al. Circadian pathway genes in relation to glioma risk and outcome [J]. Cancer Causes Control, 2014, 25(1): 25-32.
[15] 夏鹤春,牛占锋,郝少才,等. 脑胶质瘤中生物钟基因Per1 和Per2的表达及意义[J]. 山东医药,2008,48:46-47.
[16] 牛占锋,郝少才,夏鹤春,等. 脑胶质瘤组织中Per1和 Per2的表达及临床意义[J]. 宁夏医学杂志,2008,30(6): 481-482.
[17] Fu L, Pelicano H, Liu J, et al. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo [J]. Cell, 2002, 111(1): 41-50.
[18] Pluquet O, Dejeans N, Bouchecareilh M, et al. Posttranscri- ptional regulation of PER1 underlies the oncogenic function of IREα [J]. Cancer Res, 2013, 73(15): 4732-4743.
[19] Luo Y, Wang F, Chen LA, et al. Deregulated expression of cry1 and cry2 in human gliomas [J]. Asian Pac J Cancer Prev, 2012, 13(11): 5725-5728.
[20] Lee JW, Hirota T, Kumar A, et al. Development of small- molecule cryptochrome stabilizer derivatives as modulators of the circadian clock [J]. Chem Med Chem, 2015, 10(9): 1489-1497.
[21] Nangle S, Xing W, Zheng N. Crystal structure of mammalian cryptochrome in complex with a small molecule competitor of its ubiquitin ligase [J]. Cell Res, 2013, 23(12): 1417- 1419.
[22] Mokros ?, Karbownik MS, Nowakowska-Domaga?a K, et al. Haloperidol, but not olanzapine, may affect expression of PER1 and CRY1 genes in human glioblastoma cell line [J]. Biol Rhythm Res, 2016, 47(6): 865-871.
[23] Chen Z, Liu P, Li C, et al. Deregulated expression of the clock genes in gliomas [J]. Technol Cancer Res Treat, 2013, 12(1): 91-97.
[24] 陈晓巍,王 凡,陈治军,等. clock基因在脑胶质瘤组织 中的表达变化[J]. 山东医药,2013,53(10):4-6.
[25] Wang F, Li C, Yong L, et al. The circadian gene clock plays an important role in cell apoptosis and the DNA damage response in vitro [J]. Technol Cancer Res Treat, 2016, 15 (3): 480-486.
[26] Li A, Lin X, Tan X, et al. Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor-suppressive miR-124 [J]. FEBS Lett, 2013, 587(15): 2455-2460.
[27] Kriebs A, Jordan SD, Soto E, et al. Circadian repressors CRY1 and CRY2 broadly interact with nuclear receptors and modulate transcriptional activity [J]. Proc Natl Acad Sci USA, 2017, 114(33): 8776-8781.
[28] Jung CH, Kim EM, Park JK, et al. Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase- Akt-MMP-2 signaling pathway [J]. Oncol Rep, 2013, 29 (6): 2109-2113.
[29] 韩 硕. 基于胶质瘤分子分型的靶向治疗[J]. 国际神经病 学神经外科学杂志,2018,45(1):83-86.
[30] Anisimov VN. Light pollution, reproductive function and cancer risk [J]. Neuro Endocrinol Lett, 2006, 27(1-2): 35- 52.
[31] Zhang L, Yang H, Zhang W, et al. Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance [J]. J Neurochem, 2017, 142(4): 574-588.

相似文献/References:

[1]付 锴 江普查 宫 睿 王 伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
 FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[2]崔焕喜,柳 琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[3]闫 珊 徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
 YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(01):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[4]罗似亮 夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
 LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(01):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[5]呼铁民 褚会松 田 甜 王昆鹏 杨国军 杨立军 王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
 HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(01):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[6]汪超甲 综述 王 辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[7]高剑峰 姚庆和 李晓辉 龙宇波 陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
 GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[8]刘 靖 吴立权 黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
 LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(01):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[9]刘 炎 杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]
[10]刘东明 胡新华 刘 永 陈 玖 刘宏毅.脑胶质瘤病人静息态默认模式网络研究进展[J].中国临床神经外科杂志,2018,(12):821.[doi:10.13798/j.issn.1009-153X.2018.12.022]

备注/Memo

备注/Memo:
基金项目:深圳科技创新委员会基金(JCYJ20180302153611416) 通讯作者:王 诚,E-mail:wangcheng@ssmc-sz.com(2019-12-05收稿,2019-12-20修回)
更新日期/Last Update: 2020-01-25